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AC  artificial chromosome  
AI  artificial insemination  
BAC  bacterial artificial chromosome  
BSSL  bile salt stimulated lipase  
BSE  bovine spongiform encephalopathy  
r28M  bispecific antibody  
CAG  chicken beta actin  
CMV  cytomegalovirus  
COC   cumulus-oocyte complex 
CpG  cytidin-guanosin   
DNA  deoxyribonucleic acid 
eGFP  enhanced green fluorescent protein 
EPO  Erythropoetin 
ES  embryonic stem 
FSH  follicle stimulating hormone 
GFP  green fluorescent protein 
GV  germinal vesicle  
HAC  human artificial chromosome 
HIV  human immunodeficiency virus 
IGHM  Immunoglobulin µ  
IVC  in vitro culture  
IVF  in vitro fertilization  
IVM  in vitro maturation  
IVP  in vitro production  
kb  Kilobase  
LH  luteinizing hormone  
LOS  large offspring syndrome 
LR geo L 
(VSV-G) 
 
neomycin phosphotransferase and β-galactorsidase fusion gene 
expressed from Rous Sarcoma Virus 
(vesicular stomatitis virus glycoprotein pseudotyped) 
LTR  long terminal repeat  
   
MI  Microinjection  
M-MuLV  murine Moloney leukemia virus 
NT  nuclear transfer  
OPU  ovum pickup  
PRNP  prion protein 
PBS  phosphate buffered saline 
pl  pico liter  
pgk  phosphoglycerate kinase  
RNA  ribonucleic acid  
n. r.   not reported  
SEM  standard error  
SIN  self inactivating  
SOF  synthetical oviduct fluid 
TALP  Tyrode albumin lactate pyruvate 
TFF  transfected fetal fibroblast 
TRFF  transgenic fetal fibroblast 
VSV G  vesicular stomatitis virus glycoprotein  
wt  wild-type   
YAC  yeast artificial chromosome  
ZP  Zona pellucida  
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1 Introduction 
Transgenic animal research has a history of more than 25 years. Transgenic 
mammals were created with the aim to answer questions ranging from basic 
research, such as the role of differently expressed genes in pathologically altered 
organisms compared to healthy animals, which is done mostly in rodents, up to 
commercial aspects of animal breeding, such as changing milk (Wall et al., 1997) or 
body composition (Pursel et al., 1989), or the metabolism of farm animals (Golovan 
et al., 2001).  
Most transgenic research is done on rodents, but the ability to modify the genome of 
farm animals in a similar manner would be a great benefit to agriculture as well as 
veterinary and human medicine (Piedrahita et al., 1999). 
In mice several strategies for gene transfer into embryos have been developed, such 
as the production of chimeric mice by injection of pluripotent embryonic stem (ES) 
cells into mouse blastocyts as gene-driven approach (Evans and Kaufman, 1981). 
ES cells can be genetically modified via transfection with DNA (Gossler et al., 1986) 
or via homologous recombination to obtain knock-out mice or mice with homologous 
recombinated gene loci (Brem, 1993).  
In farm animals germline competent embryonic stem cells are not available, despite 
considerable efforts to isolate them (Denning and Priddle, 2003). Therefore 
transgenic livestock had to be produced by microinjection into the pronuclei of 
zygotes (Hammer et al., 1985; Brem et al., 1985), where gene integration occurs 
randomly and gene expression can not be guaranteed. Pronuclear microinjection 
works rather well in mice, where about 10 animals are required per transgenic 
founder, but efficiency in livestock is much lower. 20 pigs and 80 cattle are necessary 
for one transgenic founder in these species (Brem, 1993). Improvement of in vitro 
embryo production techniques of livestock species, particularly in cattle, reduced the 
costs of creating transgenic livestock via microinjection dramatically and allowed the 
development of nuclear transfer of cells into in vitro matured oocytes. Combined with 
targeted transgenesis via homologous recombination in somatic donor cells the 
creation of transgenic and expressing livestock became possible (Schnieke et al., 
1997). But also NT was shown to suffer from low efficiencies and the resulting 
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offspring often exhibitvarious developmental abnormalities, which are commonly 
summarized as “large offspring syndrome (LOS)” (Heyman, 2005).  
Therefore new routes of gene transfer in livestock species are still of high interest for 
biomedical research. Recent publications have shown that lentiviral vectors are 
highly efficient for the generation of transgenic mammals (for review see (Pfeifer, 
2004)), such as mouse (Lois et al., 2002a; Pfeifer et al., 2002), rat (Nakagawa et al., 
2005), pig (Hofmann, et al. 2003 ), cattle (Hofmann et al., 2003; Hofmann et al., 
2004) and chicken (McGrew et al., 2004). In our previous studies, we used HIV-1 
based lentiviral vectors which contain a self-inactivating (SIN) mutation for the 
generation of transgenic pigs and cattle (Hofmann et al., 2003a; Hofmann et al., 
2004). Oocytes and preimplantation embryos are protected by their zona pellucida 
(ZP), which is a physical barrier for viral infection. So far two different methods have 
been applied to overcome this hurdle for lentiviral transduction: a) denudation of the 
embryos by acid tyrode treatment and incubation in virus suspension (Pfeifer et al., 
2002) and b) subzonal injection of virus particles into the perivitelline space (Lois et 
al., 2002). A potential alternative to these state-of-the-art methods in lentiviral 
transgenesis is laser-based zona microdrilling and subsequent culture of embryos in 
virus suspension. Laser-assisted penetration of the ZP is routinely established, e.g. 
in human assisted reproduction techniques (ART) such as intracytoplasmic sperm 
injection (ICSI) or assisted hatching (Seif et al., 2005). The laser technology allows 
for precise and reproducible creation of a hole of desired size in the ZP without 
damaging the underlying cytoplasm (Rink et al., 1996a). This procedure is easy to 
perform and does not require special skills of the operator. 
The present study evaluates the efficacy of laser-assisted lentiviral gene transfer in 
bovine as compared to the subzonal injection technique. Both methods were used for 
oocytes and zygotes, in order to optimize lentiviral gene transfer with regard to the 
proportions of embryos surviving and expressing the transgene.  
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2 Literature 
2.1 Transgenesis in bovine and other livestock species 
Until today the number of transgenic cattle remains low. High costs and low efficiency 
of the available methods to create well expressing transgenic livestock could not be 
overcome sufficiently, although the importance and high value of such animals is 
emphasized enthusiastically by many authors (Wall et al., 1985; Eyestone et al., 
1998; Piedrahita et al., 1999; Wall et al., 1992; Wall et al., 1997; Clark, 1998; Brem 
and Brening, 1985; Chan, 1999; Clark and Whitelaw, 2003; Colman, 1996; Denning 
and Priddle, 2003; Donovan et al., 2005; Eyestone, 1994; Golovan et al., 2001; 
Grosse-Hovest et al., 2004; Hammer et al., 1985; Haskins et al., 2002; Hofmann et 
al., 2003; Hofmann et al., 2004; Hyttinen et al., 1994; Melo et al., 2005; Muller and 
Brem, 1998; Petters, 1994; Schnieke et al., 1997; Seamark, 1994; Wolf et al., 2000)  
The success of pronuclear microinjection or cloning is evident in the generation of 
transgenic cattle but its limitations have hindered progress of bovine transgenics 
(Hodges and Stice, 2003; Maga, 2005). 
 
2.1.1 Definitions  
Gene transfer is the incorporation of new DNA into organism's cells 
(http://www.ornl.gov/sci/techresources/Human_Genome/glossary/glossary_g.shtml). 
The term “transgene” was first used for animals, which had integrated in vitro 
recombinated gene constructs into their genome (Gordon and Ruddle, 1981). 
Bacterial, yeast, and higher eukaryotic cells harboring a foreign DNA fragment are 
known as recombinant or transformed cells (Houdebine, 2003). Gene constructs may 
stay episomal or integrate into the genome of somatic and/or germ line cells at one or 
more sites. Depending on the method used, integration occurs by chance (MI), or 
randomly into genes, which were found to be strongly favored as integration acceptor 
sites for HIV-1 derived vectors (Schroder et al., 2002). One major problem of 
transgenesis is mosaicism, which means that not all cell lines of the organism contain 
the transgene. Transgenic animals are hemizygote for the transgene, not 
heterozygote, because heterozygocity requires a homologous allele. Integration 
requires breaking of the DNA and its subsequent repair, thus causing the risk of 
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insertional mutagenesis. The two methods most commonly used to create transgenic 
cattle are microinjection of DNA into the pronuclei of zygotes and cloning via nuclear 
transfer.  
 
2.1.1.1 Pronuclear microinjection (MI) 
Injection of DNA into pronuclei of zygotes has been consistently used in mice since 
1981 (Gordon and Ruddle, 1981) and in farm animals since 1985, when Hammer et 
al. (1985) and Brem et al. (1985) demonstrated the feasibility of this procedure. 
About 500 – 5000 copies of foreign DNA are injected into a pronucleus, which are 
diluted in 1 – 2 pl buffer solution. Zygotes from large animals can be obtained either 
after superovulation ex vivo, or after in IVM and IVF of oocytes, collected from 
slaughterhouse ovaries or via ovum pick up (OPU) from live donor animals. Due to 
their high lipid content, zygotes of ruminants and pigs have a dark cytoplasm, which 
makes the pronuclei invisible. Centrifugation prior MI assembles the lipid granules at 
one side of the embryo and makes the pronuclei visible. This treatment did not seem 
to have any negative influence on the developmental capacity of the zygotes (Wall et 
al., 1985; Wall and Hawk, 1988).The efficiency of MI in farm animals is low (< 1%) 
(Chan, 1999) (Table 1). On average, 40 embryos of mice, 100 pig embryos, 110 
sheep embryos and 1600 bovine embryos are required for a single transgenic 
offspring (Wall et al., 1997). The behaviour of a transgene is unpredictable; the site of 
integration can not be controlled and expression may vary due to position effects 
(Wolf et al., 2000). Furthermore, endogenous genes can be destroyed by the 
integration of the foreign DNA (insertional mutagenesis). This could be a reason of 
reduced developmental capacity of pronuclear injected zygotes (Eyestone et al., 
1995). The recommended time point for microinjection in bovine is at the end of the 
S-phase of the cell cycle, where DNA synthesis occurs (Krimpenfort et al., 1991).  
For construct composition the following features are recommended 
(http://www.biotech.wisc.edu/ServicesResearch/TransgenicAnimal/TransgenicMiceor
Rats.asp):  
1) a promoter with a known cellular expression profile 
2) a genomic clone or cDNA and intron fragment containing splice donor and 
receptor sites 
3) a fragment containing polyadenylation addition sequences, to ensure mRNA 
stability 
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4) well characterized restriction sites that will allow the isolation of an injection 
transgenic fragment free of prokaryotic vector sequences  
The size of the DNA determines the molar concentration and therefore the number of 
copies of the gene per injection sample. An ideal fragment size is between 2 kb and 
20 kb. To have a fragment much under 2 kb is not recommended because, 
empirically, it usually does not integrate very efficiently. The larger the DNA or the 
more different fragments that are in the injection sample, the lower the final copy 
number of individual genes becomes in that sample 
(http://cancer.ucsd.edu/Research/Shared/tgm/pronuclear.asp). 
Attempts to counteract the position effects and to cause a targeted overexpression of 
the transgene lead to the development of complex vector systems, such as mini-
genes (Loveland et al., 2004) or artificial chromosomes (AC), being produced with 
the help of organisms such as Yeast (YAC) or bacteria (BAC). This technique allows 
addition of DNA fragments up to 250 kb into a host´s genome, as Brem et al.(1996) 
showed by introducing a YAC-DNA clone into rabbits.  
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2.1.1.2 Cloning via nuclear transfer (NT) 
Cloning is the reproduction of a cell or a whole organism without any modification of 
its genotype (Houdebine, 2003). The ability to duplicate an organism requires 
totipotency, which is defined as a cell characteristic in which the potential for forming 
all the cell types in the adult organism is retained 
(www.sivb.org/edu_terminology.asp). In farm animals true cloning can be achieved 
by embryo splitting, where genetically identical twins can be produced by splitting a 
two cell embryo (Gordon, 2003) up to the blastocyst stage (Lewis, 1994). 
Monocygotic twins are identical with respect to both nuclear and mitochondrial DNA 
(Wolf et al., 2003). 
To increase the number of genetically almost identical offspring NT has been 
developed. Oocytes contain mitochondrial DNA, which contributes to the genetic 
setting of an individual as well as the donor nucleus and can therefore, depending on 
the oocyte origin, vary (Han et al., 2004; Hiendleder et al., 2003). Three main steps 
are required for NT: 1) Removal of maternal chromatin from a recipient oocyte; 2) 
introduction of a donor nucleus into the recipient oocyte; and 3) activation of the 
reconstructed oocyte (Gordon, 2003). The donor cells can be blastomeres from 
cleavage-stage embryos (Zakhartchenko et al., 1995), fetal cells (Hill et al., 2000) or 
adult somatic cells (Wilmut et al., 1997) (Table 1). For successful development of 
embryos resulting from NT, the donor nuclei have to obtain an embryonic pattern of 
DNA replication and transcription under the control of the recipient oocytes. It is 
recommended that the donor cells should be in the M phase or G1 phase of the cell 
cycle when used for NT (Renard et al., 2002). All cells of a multicellular organism, 
except for lymphocytes, contain the same genetic information, but differ in tissue-
specific, temporal, and spatial gene expression patterns which are controlled by 
genetic and epigenetic mechanisms. Successful cloning of mammals by transfer of 
nuclei from differentiated tissues into enucleated oocytes demonstrates that 
epigenetic reprogramming can restore cellular totipotency (Shi et al., 2003). 
Incomplete or inappropriate epigenetic reprogramming of donor nuclei is likely to be 
the primary cause of failures in NT (Shi et al., 2003).  
The use of genetically modified cells as donor cells for NT has shown to be 
appropriate for targeted transgenesis in farm animals and ensures that all offspring is 
transgene. Via IVC of somatic cells over several passages, it is possible to transfect 
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stably the cells with a construct containing the gene in question, together with a 
promoter with tissue specific or ubiquitous expression. This transfection requires 
homologous recombination, which is defined as a process whereby a specific gene 
sequence within the genome is replaced with a related gene sequence using the 
cellular recombination enzymes (http://www.cardiogenesis.com/glossary.cfm). This 
process results in the modification of a specific gene. Homologous recombination is a 
rare event, which only happens at a frequency of 1 x 10 –6 targeted events per cells 
manipulated (Piedrahita et al., 1999), which is 100 times less frequent than random 
integration (Houdebine, 2003). Transfected cells are selected with a selection marker 
and can be used as donor cells accordingly (Gordon, 2003). Current studies report 
an improvement in isolating transfected mammalian cells and in diagnosing the 
incorporation of desirable vectors in NT embryos (Melo et al., 2005; Maga, 2005). 
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Table 1 Transgenic cattle  
Construct Method 
Live transgenic calves / 
injected or reconstructed 
embryo 
Expression 
of the 
transgene
Reference 
casein hlF MI1 2 / 1154 n.r. (Krimpenfort et al., 1991)
IGF-1 gene MI1 3/ 2259 n. r. (Hill et al., 1992) 
Human estrogen 
receptor gene 
MI1 1 / 4150 n. r. (Hill et al., 1992) 
chicken c-ski gene MI1,2 2 / 2555 n. r. (Bowen et al., 1993) 
EPO gene MI1 1 / 859 n. r. (Hyttinen et al., 1994) 
α-lactalbumin gene MI1 7 / 25 023 1 ♀ (Eyestone et al., 1998) 
b-galactosidase gene NT 3 / 276 n. r. (Cibelli et al., 1998) 
retroviral LR geoL 
(VSV-G) vector 
MI1 
4 / 836 (oocytes infected) 
1 / 584 (zygotes infected) 
0 / 4 
0 / 1 
(Chan et al., 1998a) 
α-lactalbumin gene MI1 18 / 36 530 n.r. (Eyestone, 1999) 
prochymosin gene NT 
3 / 213 TFF cells 
2 / 511 TRCF cells 
n.r. 
(Zakhartchenko et al., 
2001) 
BSSL gene NT 8 / 363 7 / 8 (Chen et al., 2002) 
HAC with human 
immuneglobulin loci 
NT 21 / n.r. 21 / 21 (Robl et al., 2003) 
GFP NT 4 / 350 4 / 4 (Bordignon et al., 2003)
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β- and ĸ-casein NT 11 / 456 11 / 11 (Brophy et al., 2003) 
bi-scFV r28M NT 9 / 309 9 / 9 
(Grosse-Hovest et al., 
2004) 
GFP NT 3 / 173 3 / 3 (Gong et al., 2004) 
IGHM - / + 
          IGHM - / - 
NT 
13 / 1534 
8 / 1374 
13 / 13 
8 / 8 
(Kuroiwa et al., 2004) 
lentiviral GFP vector MI1 4 / 48 4 / 4 (Hofmann et al., 2004) 
modified lysostaphin 
gene 
NT 8 / 4007 8 /8 (Wall et al., 2005)) 
1 in vitro 
2 ex vivo 
3 live calves / implanted embryos 
4 live calves / embryos transferred 
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2.1.2 Application fields for transgenic livestock 
2.1.2.1 Agriculture 
The first attempt of creating transgenic livestock was to overcome limitations of 
traditional breeding concerning selective genetic improvement for agricultural 
production traits, such as milk yield or body weight gain. Introduction of a growth 
hormone gene markedly increased growth rate and final size of mice (Palmiter et al., 
1992), but did not work well in farm animals. Transgenic pigs carrying bovine growth 
hormone genes had only a slightly enhanced growth rate and reduced levels of fat, 
but these animals suffered from widespread deleterious effects, including 
susceptibility to stress, lameness and reduced fertility (Pursel et al., 1989). Changes 
in milk composition was another attempt to establish transgene technology. 
Proposed modifications included the increase of α- and β-casein with more 
phosphorylation sites, to improve thermal stability and increase the calcium content 
of the milk (Wall et al. 1997).  
 
2.1.2.2 Biopharmaceuticals (gene pharming) 
Although expectations concerning improvement of agricultural traits in livestock 
species were not fulfilled, new uses of transgenic farm animals continued to attract 
research funding (Clark, 1998). The aim was to investigate if transgenic animals were 
capable to synthesize large amounts of recombinant proteins with appropriate post-
translational modifications, which could not be provided by prokaryotic bacteria. 
Blood serum, milk, egg white, blood, urine, seminal plasma or silk worm cocoon were 
candidates to be the source of recombinant proteins at an industrial scale 
(Houdebine, 2000). Recently it could be shown that a bispecific single-chain antibody 
could be produced in the serum of transgenic rabbits and a herd of nine cloned, 
transgenic cattle. The bispecific protein, designated r28M, was directed to a 
melanoma-associated glycoprotein and the human CD28 molecule on T cells. 
Purified from the serum of transgenic animals, the protein was stable and fully active 
in mediating target cell-restricted T cell stimulation and tumor cell killing (Grosse-
Hovest et al., 2004).  
Literature 
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Another source for recombinant protein is milk. The mammary gland is a highly 
efficient bioreactor and studies have shown that it can be the source of a variety of 
rather complex recombinant proteins (Colman, 1996; Clark, 1998). Examples were to 
add enzymes, such as human lactoferrin, to improve iron absorption, or to replace 
bovine milk protein genes with human equivalents to mimic human breast milk (Wall 
et al., 1997). Depending on the amounts of protein needed, transgenic rabbits 
(Coulibaly et al., 2002; Zinovieva et al., 1998), sheep (Duchler et al., 2002; Niemann 
et al., 1999) or cows (Thomassen et al., 2005) have been shown to be appropriate. 
But low expression levels of some recombinant proteins, serious side effects for the 
animal (when the protein enters the circulation), or insufficient post-translational 
modifications of the proteins are challenges which have to be overcome. Despite this, 
mammary gland-derived pharmaceuticals are in the final stages of product 
development (Donovan et al., 2005). 
 
2.1.2.3 Disease resistance 
Conventional breeding did – so far - not succeed to increase resistance to infections 
of the mammary gland. This provided a further application field for transgenic 
technology in farm animals. The proposed use of transgenic technologies to increase 
disease resistance in farm animals (Muller & Brem 1998) was not reported to be 
successful until 2005: Mastitis in dairy cows is often caused by Staphylococcus 
aureus. This infection of the mammary gland causes considerable financial loss in 
dairy industry all over the world (Donovan et al., 2005). Since antibiotic treatment 
often was insufficient and breeding strategies failed, a transgenic approach was 
made. Via nuclear transfer, transgenic cattle were created which expressed 
lysostaphin, an antistaphylococcal enzyme, in the epithelial cells of the mammary 
gland (Wall et al., 2005). Although the lysostaphin concentrations in the milk of 
transgenic cows were lower than expected, it seemed to be a very promising 
approach to control staphylococcus infection of the mammary gland. Development of 
inducible expression constructs may improve public acceptance, because the milk 
would only contain foreign proteins when infection with Staphylococcus aureus has 
taken place (Rainard, 2005). 
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2.1.2.4 Disease models 
Rodent models as commonly used organisms for biomedical research provide 
invaluable data for understanding human diseases (Houdebine, 2003), but they have 
certain limitations due to their small size, short gestation time, different metabolism 
and limited life span. Transgenic large animal models provide a highly useful tool for 
biomedical research, particularly in regard to xenotransplantation, chronic diseases, 
genetic defects or questions concerning the species-specific biological mechanisms, 
such as embryo-maternal communication (Wolf et al., 2003). One example, where 
murine and primate metabolism are not compatible is cystic fibrosis. In humans this 
disease is caused by mutations of the CFTR gene. Mice whose CFTR gene has 
been knocked out do not develop the disease (Houdebine, 2003). Here transgenic 
large animal models may provide more useful data, since lungs of pigs and sheep 
show similarities to man in lung anatomy and their CFTR expression patterns in 
submucosal glands provide hope that they may develop lung disease similar to that 
seen in human CF patients (Hart, 2003). Human α-1-antitrypsin (hAAT) is a plasma 
protein that inhibits elastase, a key enzyme in the inflammatory response that can 
lead to excessive tissue destruction as it is seen in CF patients (Denning and Priddle, 
2003). Therefore hAAT is a candidate protein for treatment of CF lung disease. 
Transgenic sheep were produced which expressed hAAT in their milk (McCreath et 
al., 2000).  
 
2.1.3 Viral transgenesis 
Viruses are highly efficient vehicles for the transport of genetic information into a cell. 
They use the cellular machinery for the transport of genetic information into the 
nucleus, for integration into the host genome, for transcription and translation of viral 
genome into viral proteins and for packing and discharging manifold viral particles out 
of the cell. Use of viral vectors as gene delivery tools requires modifications of the 
viral genome to exclude any risk of wt infection and resulting damage for the cell. 
 
2.1.3.1 Viral transgenesis in bovine 
Retroviral infection was the earliest method used for gene transfer into embryos. 
Preimplantation mouse embryos (at the 4-8 cell stage) were infected with Moloney 
leukemia virus (M-MuLV) and the resulting animals developed a M-MuLV-induced 
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leukemia. The infection of the embryos lead to integration of the virus into the germ 
line and the further generations showed the disease following mendelian rules 
(Jaenisch, 1976). The first report of transgenic cattle resulting from viral transgenesis 
was provided by Haskell et al. (1995). They placed retroviral packaging cells under 
the ZP of bovine embryos and produced several transgene mosaic fetuses, but no 
live animal. The first cattle via retroviral gene transfer was created by Chan et al. 
(Chan et al., 1998). They could obtain transgenic live calves from infected oocytes (4 
/ 4) as well as from infected zygotes (1 / 4). No animal showed transgene expression, 
because the viral vector was silenced shortly after birth. Two major mechanisms 
have been identified for retrovirus silencing: trans-acting factors that bind to the viral 
promoters in the LTRs and methylation of the integrated retoviral genome and 
flanking host DNA sequences (Pfeifer et al., 2002).  
Not until 2004 it could be shown that viral transgenesis lead to expressing animals. 
Bovine oocytes were infected with a modified retrovirus, a lentiviral vector, carrying a 
eGFP marker gene. They were cultured in vitro, and 8 resulting blastocysts, showing 
eGFP expression, were transferred to four recipients. Four calves from 3 
pregnancies were born. All of them showed transgene expression (Hofmann et al., 
2004). 
 
2.1.3.2 Vector design 
Viral vectors can be divided into two groups according to the basic virology of the 
parental viruses: non integrating and integrating (Pfeifer, 2004). The genome of non 
integrating viral vectors, such as adenoviruses, will get lost after several cell 
divisions, but these viruses have been shown to be useful in gene therapy 
approaches in cancer research (Gallo et al., 2005), or new developments of vaccines 
in veterinary medicine (Ferreira et al., 2005). For stable, long term expression in 
animals, only integrating viral vectors are suitable, since they are passed from cell to 
cell. 
The first step of viral vector design is to identify the viral sequences responsible for 
replication and pathogenesis and those necessary for the production of infectious 
particles. Dispensable genes are deleted from the viral genome to reduce replication, 
pathogenicity and expression of immunogenic viral antigens. The transgene with 
transcriptional regulatory elements is inserted into the vector construct. A 
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recombinant virus is generated by supplying the missing gene products required for 
replication and virion production in trans (Verma and Weitzman, 2005). (Fig. 1) 
 
Fig 1 Lentiviral vector design (Pfeifer, 2004) 
A: wild-type viral genome; rectangles: flanking LTRs, dark circle: pathogenic genes, will be 
deleted; light circles: packaging part of the viral genome 
B: viral vector flanked by LTRs, containing necessary cis-acting sequences and the transgene 
(lengthwise rectangle); 
C: viral proteins essential for production of infectious particles are expressed in trans by the 
packaging cell (D) 
E: envelope protein (env) is provided that ensures infection of a broad spectrum of target cells, 
such as VSV-G 
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2.1.3.3 RNA virus vectors 
The most commonly used RNA virus vectors are derived from retroviruses, a large 
family of enveloped RNA viruses found in all vertebrates. They can be classified into 
oncoretroviruses, lentiviruses and spumaviruses (Verma and Weitzman, 2005).  
 
2.1.3.4 Retrovirus 
Retroviruses are enveloped virus particles of approximately 100 nm in size, 
containing two copies of the viral RNA genome, which are surrounded by a cone 
shaped core (Fig. 2). The viral RNA contains three essential genes, gag, pol, and env 
and is flanked by long terminal repeats (LTR) (Verma and Weitzman, 2005). The gag 
gene encodes for the core proteins capsid, matrix, and nucleocapsid, which are 
generated by proteolytic cleavage of the gag precursor protein. The pol gene 
encodes for the viral enzymes protease, reverse transcriptase, and integrase, which 
are usually derived from the gag-pol precursor. The env gene encodes for the 
envelope glycoproteins, which mediate virus entry. 
After binding to its receptor, the viral capsid enters the cell through membrane fusion. 
The viral enzyme reverse transcriptase converts viral RNA into a double-stranded 
proviral DNA, which is associated with viral proteins to mediate integration of the 
provirus into the host cell genome. Disruption of the nuclear membrane is required 
for the preintegration complex to gain access to the chromatin, and productive 
transduction by retroviral vectors is strictly dependent on target cell mitosis shortly 
after entry (Kay, Glorioso, et al. 2001). Host cell transcription factors initiate 
transcription starting at the LTR, and new viral particles are formed at the plasma 
membrane. Two copies of viral RNA assemble together with viral precursor proteins, 
which are subjected to processing by the viral protease. This results in maturation of 
the virion (Verma and Weitzman, 2005).  
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Fig 2 Model of a retrovirus  
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2.1.3.5 Lentiviral vectors  
Lentiviruses encode up to six more proteins, compared to simple retroviruses, which 
contribute to virus replication and persistence of infection (Verma and Weitzman, 
2005). They can transduce non-dividing cells (Naldini et al., 1996a), because of an 
active transport mechanism into the nucleus (Follenzi et al., 2000; Zennou et al., 
2000). This is an important difference between lentiviruses and other retroviruses, 
since other retroviruses can only integrate when the host cells are actively replicating 
at the time point of infection (Miller et al., 1990). HIV-1 is the best studied lentivirus 
(Pfeifer, 2004) and most often used to design lentiviral vectors (Verma and 
Weitzman, 2005). HIV-1 derived vectors were found to favor genes as integration 
sites. It was suggested that integration may be promoted by increased chromatin 
accessibility in transcribed regions. Alternatively integration may be promoted at 
active genes by favorable interactions between HIV preintegration complexes (PICs) 
and locally bound transcription factors (Schroder et al., 2002). 
Lentiviruses have been isolated from sheep (visna/maedi virus), goats (caprine 
arthritis encephalitis virus), cattle (bovine immunodeficiency virus), horses (equine 
infectios anemia virus, EIAV), cats (feline immunodeficiency virus, FIV), monkey 
(simian immunodeficiency virus), and humans (human immunodeficiency virus, HIV). 
The first report of transgenic mammals, created via lentiviral vectors, were published 
in 2002 (Lois et al., 2002; Pfeifer et al., 2002). Mouse embryos were infected at the 
zygote or morula stage with a HIV-derived SIN vector, carrying the GFP reporter 
gene. Both studies showed transgene integration, transgene expression and germ 
line transmission of viral gene constructs (Pfeifer, 2004). Lois et al. also showed the 
feasibility of lentiviral transgenesis in rats and demonstrated tissue-specific 
expression of GFP by using tissue-specific promoters in mice (Lois et al., 2002). The 
production of transgenic livestock by lentiviral vectors has been shown to be a less 
expensive alternative to MI or NT, since GFP expressing pigs as well as GFP 
expressing cattle could be produced efficiently. In both species stable long-term 
expression and germline transmission occurred (Hofmann et al., 2003; Hofmann et 
al., 2004; Whitelaw et al., 2004). Lentiviral vectors are also suitable to create 
genetically modified birds. Transgenic chicken stably expressed a reporter gene up 
to the F2 generation (McGrew et al., 2004), and tissue-specific expression in birds 
was reported in quails, where Scott et al. demonstrated that the use of a GFP vector, 
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driven by the human synapsin gene I promoter lead to the expression of GFP in 
neurons, which was persistent across multiple generations (Scott and Lois, 2005). 
Many studies using lentiviral vectors for gene transfer have demonstrated 
unexpected high frequencies of transgenic animals expressing the transgene (Lois et 
al., 2002; Pfeifer et al., 2002; Hofmann et al., 2003; Hofmann et al., 2004; Whitelaw 
et al., 2004). Due to this fact, they suggested lack of gene silencing. But the analysis 
of the epigenetic regulation of individual integrants in lentiviral transgenic animals in 
vivo showed, that one-third of the proviruses exhibited only low or undetectable 
levels of expression and a high degree of methylation of CpG dinucleotides. This 
indicated that DNA hypermethylation played a role in lentivirus silencing in transgenic 
animals and that lentiviral transgenesis was affected by varying degrees of 
epigenetic modification (Hofmann et al., 2006).  
For vector design, the viral genome is separated in two parts: the vector and the 
packaging constructs. The vector construct contains the LTRs, necessary cis-acting 
sequences and the transgene. The viral proteins essential for production of infectious 
particles are expressed in trans by the packaging cells (Pfeifer, 2004). The HIV-1 
glycoprotein env has a highly restricted host range. It only infects cells containing 
CD4 and coreceptors. To broaden the host range of lentiviral vectors, they can be 
pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G) env, which is 
provided in trans by the packaging cell line, and imparts a wide tropism (Naldini et al., 
1996).  
To lower the possibility of an accidental activation of cellular oncogenes by random 
integration of the vector into the host genome, SIN-lentiviral vectors have been 
designed, in which the viral enhancer and promoter sequences within the LTRs have 
been deleted (Miyoshi et al., 1998).  
The use of SIN vectors might also avoid gene silencing, because it was postulated 
that an active viral promoter sequence might attract the host silencing machinery to 
the integrated provirus (Pfeifer, 2004). Promoters, which have been used, are for 
example the human cytomegalovirus immediate early promoter (CMV) (Naldini et al., 
1996), the promoter of the human phosphoglycerate kinase gene (PGK) (Follenzi et 
al., 2000), the human ubiquitin-C promoter (Lois et al., 2002), and the CAG promoter 
(a chicken beta-actin / CMV-compound promoter) (Pfeifer et al., 2002). Tissue-
specific expression can be achieved by incorporating specific promoter sequences. 
For example, a lentiviral vector, containing the human keratin K14 promoter (LV-K14) 
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was injected into porcine zygotes. Resulting LV-K14 transgenic animals expressed 
GFP specifically in basal keratinocytes of the skin (Hofmann et al., 2003) (Fig. 3).  
The use of lentiviral vectors is limited by the size of the RNA genome. The maximal 
packaging capacity of an HIV-1 based vector particle is approximately 10 kb, which 
restricts the size of the transgene plus internal promoter to less than 8.5 kb. 
The virus titer for successful viral transduction in embryos seems to be approximately 
109 IU / ml (Hofmann et al., 2003, Chan, Homan, et al. 1998 ). 
 
Fig 3 Lentiviral vector 
Carrying the K14 promoter (LV-K14, top). Arrow, self-inactivating mutation; eGFP, enhanced 
green fluorescent protein; LTR, long terminal repeat; ppt, polypurine tract;W, woodchuck 
hepatitis responsive element  
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2.2 In vitro production (IVP) of bovine embryos 
In vitro production of embryos includes collection of cumulus-oocyte complexes 
(COCs), maturation of COCs, capacitation of sperms, fertilization and subsequent 
culture of presumptive zygotes. All procedures happen in an artificial culture 
environment. 
 
2.2.1 History 
For IVF, the discovery that sperms have to undergo capacitation before fertilization 
was indispensable (Austin, 1951; Chang, 1951). In 1986, Parrish developed  the so 
called swim-up method for capacitating bull sperm, which is still in use today (Parrish 
et al., 1986). The first calf from IVM and IVF was born in 1988 (Lu et al., 1988). 
Today routine protocols for bovine are widely established and allow the use of bovine 
embryo technologies, besides its classical use in animal breeding, as research tool 
for transgenesis (Galli et al., 2003).  
 
2.2.2 Recovery of ovaries and oocyte collection 
In common, ovaries for routine IVP procedures are obtained from a local abattoir. 
Transport medium, storage time and temperature must be taken into consideration 
(Gordon, 2003). PBS or 0.9 % saline are generally used for the transport to the 
laboratory. Storage time is recommended within 1 –2 hours at a temperature of 30°C 
(Gordon, 2003), but no adverse effect on developmental competence of oocytes was 
found at storage times up to 12 h at temperatures from 15 to 21°C (Schernthaner et 
al., 1997).  
For oocyte collection, dissection of intact antral follicles (2 – 8 mm) and their 
subsequent carefully controlled rupture was established in the 1980s. This technique 
allowed recovery of more high quality oocytes with the least disruption of the 
surrounding cumulus cells than aspiration (Gordon, 2003).  
Aspiration of follicles has been most commonly employed method since it has been 
shown to be three times faster than dissection. Bovine follicles were aspirated with 
18 – 22 g needles and 3 – 20 ml syringes or with 16 – 19 g needles attached to a 
vacuum pump using pressures of 75 – 100 mmHg (Gordon, 2003). Using a 17 g 
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needle with 55 mm Hg resulted in the highest number of viable oocytes because a 
reduction of pressure reduces the rate of oocytes, which are stripped of cumulus 
cells (Fry et al., 1997). 
Slicing, cutting and dissection of the bovine ovary for recovering immature oocytes 
can be combined with ovary slicing. Many authors recommend the use of ovary 
slicing, since oocyte yield could be more than doubled in comparison to aspiration 
(Gordon, 2003). This is due to the fact that even follicles located under the ovarian 
surface are collected as well, whereas during aspiration only oocytes from follicles at 
the surface are collected. It was shown that developmental competence of oocytes 
increased with their size, and oocytes with the largest diameters were found at the 
follicles at the surface of the ovary and collected by aspiration (Arlotto et al., 1996). 
 
2.2.3 Assessing oocyte quality 
One example for selection of oocytes for IVM by morphological parameters is shown 
in Table 2. This method is used by many groups (Hazeleger et al., 1995; Khurana 
and Niemann, 2000; de Wit and Kruip, 2001), although a broad variety of more 
detailed classifications can be found (Gordon, 2003). It could be shown that most 
class I oocytes were at the GV stage and showed higher blastocyst formation after 
fertilization than oocytes of lower quality classes (Cetica et al., 1999).  
 
 
Table 2 Criteria used to classify bovine oocytes 
Class Cumulus Cells Cytoplasm 
I > 5 dense layers of cumulus cells even, dense, finely granulated
II 3-5 dense layers of cumulus cells 
finely granulated to moderate 
size granulated 
III 
few layers of cumulus cells with 
gaps 
granulated and irregular 
IV denuded small, granulated and irregular 
 
Besides cumulus cells, constituents of the follicular fluid and their concentrations 
have shown to be useful for assessing oocyte quality. In addition to morphological 
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parameters, progesterone, estradiol-17β and insulin-like growth factor-I (IGF-I) 
concentrations were measured in the follicular fluid of each follicle and attempts were 
made to find a correlation with the developmental competence of the oocyte. It could 
be shown that the progesterone content of the follicular fluid was lower when it 
contained well developing oocytes (Hazeleger et al., 1995). Another study 
demonstrated that the estradiol-17β content of high quality follicles should be above 
100 pg/ml (Araki, 1998). 
One more parameter to define the developmental competence of bovine oocytes is 
their diameter. Oocytes smaller than 110 µm are still transcriptionally active and have 
a reduced ability to resume meiosis (Lechniak et al., 2002).  
 
2.2.4 Oocyte maturation  
In mammalian species such as the cow, some hours before the rupture of the follicle 
and ovulation, the fully grown oocyte in the preovulatory follicle resumes meiosis, 
progressing from prophase of the first meiotic division to metaphase II. This 
maturation process, which is accompanied by complex changes in the protein 
phosphorylation pattern (Tomek et al., 2002), transforms the primary oocyte into a 
mature secondary oocyte. This includes a series of modulations of organelles and 
inclusions, as well as a period of active transcription, which is necessary for the 
oocyte to achieve meiotic and developmental competence (Hyttel et al., 1997). 
Oocyte transcription, including nucleolus function with ribosomal RNA syntheses, is 
activated in the secondary follicle and is maintained up to an oocyte diameter of 
about 110 µm in the 3 mm tertiary follicle (Hyttel et al., 1997). In the dominant follicle, 
full developmental competence is reached during the final maturation, initialized by 
the preovulatory LH surge, which occurs 24 h prior ovulation.  
The final maturation can be classified into nuclear and cytoplasmic maturation. Four - 
8 hours after the LH surge germinal vesicle breakdown occurs, which is a Ca 2+ 
dependant process (He et al., 1997), and is characterized by gradual chromatin 
condensation, the disappearance of a compact nucleolus and nuclear membrane 
disintegration. This is the beginning of nuclear maturation. Then, chromosomes 
condense into a compact form and arrange themselves on the equatorial plate of the 
meiotic spindle, and the first meiotic division is completed by extrusion of the first 
polar body. Meiosis progresses to metaphase II, but is not completed unless sperm 
penetration occurs. Two kinases play important roles in the nuclear maturation: 
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maturation-promoting factor (MPF) and mitogen-activated protein (MAP) kinase, 
which is necessary for metaphase II arrest (Gordo et al., 2001). 
During cytoplasmic maturation, cortical granules align along the oolemma, 
mitochondria are rearranged, the lipid content increases to provide energy during 
maturation and early embryonic development (Kim et al., 2001), the Golgi 
compartment is reduced and ribosomes are redistributed (Hyttel et al., 1997). 
During final maturation, the follicle itself undergoes a series of changes. The 
membrane granulosa cells stop synthesizing estradiol and a marked increase in 
progesterone synthesis together with an extensive expansion of the cumulus cells 
can be observed. The extensions of the corona radiata cells, which penetrate the ZP, 
are retracted, indicating that communication between the oocyte and its surrounding 
support cells decreases after the onset of final maturation (Gordon, 2003). 
In response to the LH surge, cumulus cells secrete hyaluronic acid, a non-sulphated 
glycosaminoglycan bound to the cumulus cells by linker proteins. During cumulus 
expansion the hyaluronic acid becomes hydrated and the cumulus cells are 
embedded in a mucified matrix. This process is called mucification. Both, expansion 
and mucification of cumulus cells are regulated by oocyte-secreted factors. After 
ovulation, the oocyte actively participates in degradation of the cumulus matrix 
(Gilchrist et al., 2004) and leaves herself within a few hours naked in the oviduct. 
To achieve oocyte maturation in vitro, the first step required is selection of 
appropriate COCs (see above). Culture media used in cattle IVM are usually 
bicarbonate-buffered systems containing basic physiological saline with the addition 
of pyruvate, lactate and glucose. Different ion concentrations and levels of energy 
are in use. The media are usually supplemented with serum or albumin and 
antibiotics. More complex media contain amino acids, vitamins, purines, hormones, 
growth factors, cytokines or steroids. A 24-hour culture period has been regarded to 
be sufficient for the completion of nuclear maturation (Gordon, 2003).  
Criteria for evaluating the quality of the oocytes after maturation are the extrusion of 
the first polar body, which should have taken place in about 80 – 90 % of the oocytes 
after a 24 hour maturation period (Gordon, 2003).  
Another aspect for assessing the quality of maturation is the degree in cumulus 
expansion as shown in Table 3 (Hunter and Moor, 1987). 
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Table 3 Degrees of cumulus cell expansion 
Grade 1: full cumulus 
cell expansion 
extremely adhesive nature and enlargement of the cumulus 
cells, at least x 3 oocyte diameters (>300 µm) away from the 
ZP 
Grade 2: moderate 
cumulus cell expansion 
expansion of the cumulus cells x 2 diameters (>200 µm) away 
from the ZP 
Grade 3: slight cumulus 
cell expansion 
cumulus cells are tightly adherent to the ZP 
 
Furthermore the distribution of mitochondria gives information about the quality of the 
maturation process (Bavister, 2000). Various staining methods together with confocal 
microscopy and ultrastructural analyses revealed more detailed information about 
processes in the maturing oocyte (Gordon, 2003). 
 
2.2.5 In vitro fertilization (IVF) 
Fertilization includes capacitation and acrosome reaction of sperms, fusion of 
gametes and development of pronuclei. Oocytes must have reached metaphase II of 
the second meiotic division. 
Capacitation includes a number of reversible chemical reactions, which remove 
epidydimis derived proteins, to allow the sperm for penetration of the oocyte (Gordon, 
2003). Presence of extra-cellular Ca 2+ is essential for the reaction and addition of 
heparin, a glucosaminoglycan, to the capacitation medium allows capacitation in vitro 
(Mahmoud and Parrish, 1996). During capacitation an increase in motility of the 
sperm tail can be observed. This so called hyperactivation is as well Ca 2+ dependent 
and may facilitate the penetration of the cumulus matrix of the oocyte (Ho and 
Suarez, 2001).  
During the acrosomal reaction the outer acrosomal membrane of the sperm 
amalgamates with the overlying plasma membrane, to allow the dispersal of 
acrosomal contents. This is essential for penetration of the ZP (Gordon, 2003).  
Penetration of the sperm activates the oocyte, which accomplishes the second 
meiotic division. Furthermore this activation induces several changes in the 
cytoplasm of the oocyte, such as the influx of calcium, which allows release of the 
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cortical granules to prevent penetration of more sperms. This activation enables the 
oocyte to develop pronuclei and form a zygote. 
To prepare semen for fertilization in vitro and select only highly motile sperms, 
several methods were developed to ensure appropriate capacitation and acrosome 
reaction. Bovine IVP is usually performed with frozen-thawed semen from AI stations. 
This ensures a high standard of semen quality (Gordon, 2003).  
The swim up procedure was developed 1986 by Parrish et al. (Parrish et al., 1986), 
where frozen-thawed sperm is placed at the bottom of a tube and covered with TALP 
medium. During 1 – 2 hours of incubation time motile sperms swim upwards and 
undergo capacitation and acrosome reaction. After one or two washing steps with 
fresh TALP medium the sperm suspension is ready for use. Another regularly used 
method is the Percoll gradient-based separation of motile sperms, developed by 
Gorus et al. (Gorus and Pipeleers, 1981). The method consists of the filtration of 
semen through an isotonic Percoll layer and subsequent centrifugation of the cell 
pellet on a preformed continuous Percoll gradient. After fractionation of the density 
gradient, immotile spermatozoa are recovered at lower density, whereas an increase 
in progressive velocity is measured for spermatozoa collected at higher densities.  
Media used for IVF are for example the TALP medium, which is a modified Tyrode 
preparation containing 25 mM sodium bicarbonate and BSA. It is further modified 
with varying amounts of energy sources (Gordon, 2003). Furthermore modified SOF, 
which is supplemented with essential amino acids, non-essential amino acids, 
glutamine and glycine, is in use for bovine IVF (Gordon, 2003). Coincubation times of 
oocytes and sperm vary between 18 and 24 hours. Rehmann et al (Rehman et al., 
1994) found that a 24 hour period of co-incubation of cattle oocytes and frozen 
thawed sperm resulted in the highest fertilization rates, but they were significantly 
lower for shorter periods of 4 – 12 hours.  
 
2.2.6 In vitro culture (IVC) 
Culture of presumptive bovine zygotes was, until the 1980s, only possible up to the 8 
– 16 cell stage, where development stopped (Eyestone et al., 1987). This so called 8-
cell block could be overcome by co-culture of the early embryos with bovine oviduct 
epithelial cells (Eyestone et al., 1987). The development of cell free, conditioned 
media followed, where only the supernatant of cultured cells was used to cultivate 
bovine embryos to the blastocyst stage (Eyestone and First, 1989).  
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Synthetic oviduct fluid (SOF) was originally based on the biochemical analysis of 
ovine oviductal fluid, but was subsequently modified by the addition of amino acids 
(Gordon, 2003). Today, SOF is one of the media widely used for bovine embryo 
culture in vitro. 
Current efforts tend to develop chemically defined protein free media. Reports started 
at 1991, where it could be shown that blastocyst formation was possible in chemically 
defined protein free medium (Pinyopummintr and Bavister, 1991). Until today 
blastocyst rates of these culture systems remain low (Oyamada and Fukui, 2004). 
 
2.2.7 Zona pellucida 
2.2.7.1 Structure and function: 
The proteins of the zona pellucida are synthesized by the oocyte and the granulosa 
cells to form an extra-cellular-matrix (ECM) of concentric layers consisting of cross-
linked zona proteins 1 – 3 (Herrler and Beier, 2000). Zona protein 2 and 3 form 
filaments of repeating heterodimers which are cross-linked by dimeric zona protein 1 
(Fig 4.) (Green, 1997). All ZP proteins are sulfated glycoproteins (Green, 1997). The 
ZP induces sperm-oocyte interaction, acrosome reaction and prevents polyspermy. It 
also prevents disaggregation of the noncompacted blastomeres and the premature 
attachment to the oviductal end endometrial surface. It protects the embryo against 
toxins, bacteria, viruses and phagocytes (Herrler and Beier, 2000). After fertilization, 
hardening of the ZP occurs, which is the result of the formation of disulfide linkages 
together with specific proteolysis (Iwamoto et al., 1999).  
 
Fig 4 Two dimensional structure of the zona pellucida  
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2.2.7.2 Drilling the ZP 
Undesired ZP hardening could be induced by in vitro culture and may hamper 
implantation (De Vos and Van Steirteghem, 2000).  
To overcome this problem, some authors recommend zona drilling (De Vos and Van 
Steirteghem, 2000). Beside that aspect, some other biotechnological applications, 
such as ICSI, blastomere biopsy or polar body biopsy, also require a hole in the ZP, 
its partial or total removal. Chemical removal or thinning of the ZP is usually 
performed with Tyrode´s acid or pronase, which exhibit embryos to additional stress, 
such as changes in pH or osmolarity. Mechanically drilled holes by a needle require 
high technical skills to achieve holes of reproducible size and shape without hurting 
the oocyte or embryo (Herrler and Beier, 2000). Various reports in the literature 
demonstrate the feasibility of laser-assisted zona drilling (Herrler and Beier, 2000).  
 
2.2.8 Cumulus cells 
2.2.8.1 In vivo 
Although numerous data on the physiological pathways by which the cumulus 
oophorus influences oocyte maturation and ovulation are available, its exact function 
during mammalian fertilization still needs to be identified (Tanghe et al., 2003a). The 
beneficial effects of cumulus cells during the fertilization process of cattle can be 
explained by: 1) attracting, trapping and selecting sperm, 2) faciliating sperm 
capacitation, acrosome reaction and penetration or by 3) preventing precocious 
hardening of the ZP. It is known that a bovine oocyte is ovulated with a covering of 
expanded cumulus cells and that these cells are dispersed within the ampulla of the 
oviduct within only few hours after ovulation (Lorton and First, 1979). Therefore the 
oocyte is probably fertilized cumulus free, but cumulus cells in the immediate vicinity 
of the oocyte create a microenvironment that is favourable for fertilization (Hunter, 
1998). 
 
2.2.8.2 In vitro 
Unlike in vivo, the cumulus cells are tightly attached to the in vitro matured oocyte 
(Park et al., 1989). Several studies confirm that removal of cumulus cells strongly 
decreases developmental capacity (Cox et al., 1993; Zhang et al., 1995). But 
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denuding oocytes before fertilization is necessary for some micromanipulation 
techniques such as microinjection, or to evaluate morphological aspects of oocyte 
quality, such as polar body extrusion, cytoplasm morphology of the oocyte or the 
extent of the perivitelline space. Furthermore cumulus cells must be removed when 
oocyte-sperm interactions are studied (Tanghe et al., 2003).  
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2.3 Laser application 
2.3.1 Presumptions for the ideal laser 
It should provide a touch-free objective-delivered accessibility by the culture dish and 
the aqueous medium. 
The laser should be affordable and easily adapted to any existent inverted 
microscope. 
The laser target interaction process should be controlled accurately and produced 
the ZP opening with no mechanical, thermal or mutagenic side effects (Germond et 
al., 1995). 
 
2.3.2 Lasers emitting at the UV spectrum (10 – 380 nm) 
Tadir et al. (1991) were the first who used a solid-state ultraviolet laser (Nd :YAG, 
wavelength 1064 nm) for drilling the ZP. But the resulting damage in the ZP was 
quite inconsistent. ArF-excimer laser emtting at 193 nm was first reported to allow ZP 
drilling of mouse oocytes with no detectable heating or structural damage of the 
surroundings (Palanker et al., 1991). Emitting in UV-spectrum this cold light laser 
was strongly absorbed by water and had a penetration depth of < 1 µm. This required 
a wave guide, e.g. an airfilled micropipette, to touch the ZP directly for drilling. 
Neer et al. studied longer wavelengths (266 nm, 308 nm, 366 nm, 532 nm), which 
were less absorbed by water and enabled a non-touch mode to drill holes in ZPs. 
These authors concluded, that a 308 nm XeCl-excimer laser was best suited to 
induce photoablation of ZPs (Neer et al., 1992). After drilling a tangential trench in 
the ZP of mouse oocytes, fertilization rate significantly improved after fertilization with 
sperm of long time vasectomized mice (el Danasouri et al., 1993). But using 
wavelengths in the UV spectrum, has dangerous effects on DNA. The absorption 
maximum for DNA is 266 nm and lasers operating close to this wavelength could not 
exclude a possible harm to genetic structures (Ebner et al., 2005). Therefore the 
possible cytotoxicity and mutagenicity excluded lasers, working in the UV spectrum, 
from IVP procedures (Kochevar, 1989).  
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2.3.3 Lasers emitting at the infrared spectrum (780 nm – 50 µm) 
Strong light absorption bands by water are also exhibited in the infrared spectrum. 
The erbium-yttrium aluminium garnet (YAG) laser with 2.9 µm wavelength is close to 
the strongest water absorption peak. The laser beam is guided through a quartz fiber 
and is brought into direct contact with the zona pellucida. In human assisted 
reproduction it has been shown to be save and efficacious. Births of healthy babies 
were reported after drilling the ZPs of oocytes prior fertilization (Antinori et al., 1994) 
and ultrastructural examination of human unfertilized oocytes and preimplantation 
embryos showed no damage of the underlying oolemma (Obruca et al., 1997).  
A laser system which does not require direct contact to the oocyte, is the 1.48 µm 
diode laser beam. It also operates in the infrared spectrum of light but is focused 
through a microscope objective, which allows a nontouch microdrilling of the ZP while 
maintaining a high degree of accuracy under conventional culture conditions (Rink et 
al., 1996). SEM images demonstrate high quality of the drilling mode since the drilled 
trench has a precise cylindrical shape with a smooth surface and regular incision 
edges (Germond et al., 1995b; Rink et al., 1996). 
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3 Material and Methods 
3.1 Virus production 
The self inactivating (SIN) lentiviral vector, which carries the eGFP reporter gene 
under the control of the human phosphoglycerate kinase (PGK) promoter, was 
produced as recently described (LV-PGK; (Hofmann et al., 2003)). In brief, lentiviral 
particles were produced by transient transfection of packaging cells. The viral 
particles were concentrated as previously described (Pfeifer et al., 2002b). Virus titer 
was measured by FACScan analysis (Becton-Dickinson, New Jersey, USA) of 
infected HEK293T cells. Virus titer is indicated in infectious units/ml (IU/ml), which 
represents the number of infectious viral particles/ml. 
 
3.2 In vitro production of bovine embryos 
Unless otherwise indicated, all chemicals were purchased from Sigma-Aldrich 
(Steinheim, Germany) and all procedures were performed at 39°C. All media were 
equilibrated in the incubator at maximum humidity, 39°C, and 5% CO2 in air or in 5% 
CO2, 5% O2, 90% N2 for at least 90 min prior use.  
Ovaries were collected at a local slaughterhouse and transported to the laboratory at 
25°C in phosphate-buffered saline (PBS). Cumulus-oocyte-complexes (COCs) were 
obtained by aspiration of 3 - 8 mm follicles. COCs with complete and dense layers of 
cumulus cells were selected for in vitro maturation and randomly distributed to the 
different treatment groups. Selected COCs were washed three times in maturation 
medium MPM (modified Parker medium), supplemented with 10% estrous cow serum 
(ECS), 0.025 units/ml follicle-stimulating hormone (FSH; Sioux Biochemical, Inc., 
Sioux Center, USA) and 0.0125 U/ml luteinizing hormone (LH; Sioux Biochemical, 
Inc.) at room temperature. Groups of 35 - 40 oocytes were transferred to 4-well 
plates (Nunc, Roskilde, Denmark) with 400 µl MPM and maintained for 19 – 20 h at 
39°C in an atmosphere of 5% CO2 in humidified air.  
Before MD or MI, cumulus cells were removed from oocytes by vortexing for 3 min in 
modified PBS (mPBS; PBS supplemented with 3 mg/ml BSA and 50 µg/ml 
gentamicin) containing 4 mg/ml hyaluronidase. If oocytes were not completely 
denuded, remnant cumulus cells were removed by gentle pipetting. Afterwards, the 
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denuded oocytes were washed three times in fresh mPBS (without hyaluronidase). 
Only oocytes showing a dense, evenly granulated cytoplasm were selected for 
further treatment. 
Matured COCs or treated denuded oocytes were washed three times in fertilization 
medium Fert Talp (Tyrode albumin lactate pyruvate) supplemented with sodium 
pyruvate (2.2 mg/ml), heparin sodium salt (2 mg/ml), BSA (6 mg/ml) and transferred 
to 400-µl droplets of Fert Talp in groups of 35 - 40. Frozen-thawed spermatozoa were 
subjected to the swim-up procedure for 90 min (Parrish et al., 1986b). Afterwards, 
COCs or treated oocytes were co-incubated with spermatozoa (1 x 106 cells/ml) in 
the same medium for 18 h at 39°C in a humidified atmosphere of 5% CO2 in air. 
Presumptive zygotes were denuded by vortexing in mPBS supplemented with 4 
mg/ml hyaluronidase and washed three times in synthetic oviduct fluid (SOF) 
medium enriched with 10% ECS, 4% 50x BME (Basal Medium Eagle) and 1% 100x 
MEM (Minimum Essential Medium). 
After treatment (MI or MD), zygotes were washed three times in SOF, transferred in 
400-µl droplets of culture medium, and maintained for 8 days in an atmosphere of 5% 
CO2, 5% O2, and 90% N2 at 39°C and maximum humidity. Sham-treated zygotes (MI 
of buffer or MD without incubation in virus suspension) which were cultured under the 
same conditions, served as controls.  
 
3.3 Subzonal virus injection 
Concentrated lentivirus (~ 100 pl, 2.5 x 109 IU/ml) was injected into the perivitelline 
space of oocytes or zygotes through a heat pulled glass capillary without damaging 
the plasma membrane as previously described (Fig. 5; (Hofmann et al., 2003a; 
Hofmann et al., 2004)). 
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Fig 5 Subzonal microinjection of a bovine oocyte 
 
 
3.4 Microdrilling and virus coincubation 
MD of denuded oocytes or zygotes (groups of 20 – 30) was performed in 40-µl 
droplets of mPBS, covered with mineral oil in a 3.5-cm petri dish (Nunc, Roskilde, 
Denmark). Laser beams were generated by a diode laser (wavelength of 1.48 µm) 
using an Octax Laser ShotTM system mounted on a light microscope (Axiovert 100; 
Zeiss, Göttingen, Germany). Laser beams of 3 ms were directed tangentially against 
the ZP three or four times to create an opening larger than 40 µm (Schmoll et al., 
2003) (Fig. 8). The hole was generated close to the polar body, where the space 
between oolemma and ZP has the largest diameter (Fig. 6). 
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Fig 6 Microdrilled bovine ooycte 
 
 
After MD, oocytes and zygotes were washed three times in Fert Talp and SOF, 
respectively. For transduction of oocytes and zygotes 0.5 µl of concentrated virus 
stock (2.5 x 109 IU/ml) was added to 20-µl droplets of the respective culture medium 
(Fert Talp for oocytes, SOF for zygotes), which were covered with mineral oil. After 
incubation (39°C, 5% CO2 in humidified air) for 4 h, oocytes and zygotes were 
washed at least six times in fresh medium to remove remaining virus.  
The time schedule for treatment of oocytes and zygotes is outlined in Fig. 7. The 
period for microdrilling and virus coincubation or virus injection was before the 
fertilization period in the oocyte groups and after fertilization in the zygote groups. 
Thus, fertilization was started 24 - 25 h and 19 - 20 h after onset of oocyte maturation 
in the oocyte and zygote treatment groups, respectively. The duration of maturation, 
fertilization and culture was the same for oocytes and zygote treatment groups. 
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Fig 7 Treatment schedule for oocytes and zygotes 
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Fig 8 Schematic diagram of the microdrilling procedure 
 
 
 
 
3.5 Effect of treatment and developmental stage 
Expression of eGFP in blastocysts was visualized using an inverted microscope 
(Axiovert 200; Zeiss) with eGFP specific filter (# 13; Zeiss) and documented with a 
digital camera (Axio Cam; Zeiss). Blastocyst morphology was evaluated on day 8 on 
brightfield images. MI and MD experiments were performed on the same day, by the 
same operator and with the same batch of oocytes or zygotes. 
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3.6 Determination of polyspermy rate 
To assess, if perforation of the ZP enhances polyspermy, pronuclear formation in 
zygotes was analyzed by orcein staining. MD oocytes were incubated with 106 
spermatozoa/ml for 18 h or for 4 h, or with 0.5 x 106 spermatozoa/ml for 8 h. A control 
group of denuded oocytes with an intact ZP was incubated with 106 spermatozoa/ml 
for 18 h. Afterwards, presumptive zygotes were immobilized between a slide and a 
cover slip and fixed for at least 24 h in ethanol/acetic acid (3 / 1). After fixation, orcein 
solution (0.75%) was dropped under the cover slip and pronuclei were counted 
immediately. 
 
3.7 Statistics 
Cleavage rates, blastocyst rates and rates of eGFP positive blastocysts were 
analyzed by the General Linear Models (GLM) procedure using the SAS program 
version 8.2 (SAS Institute Inc., Cary, NC, USA). The following model was used to 
estimate effects of treatment (MI vs. MD) and developmental stage (oocyte vs. 
zygote): 
 
Yijkl = µ + stagei + treatj + virusk + εijkl 
 
with: 
Yijkl = an observation for cleavage rate, blastocyst rate, expression rate for record ijk; 
µ = expected mean of Y; stagei = fixed effect of stage i, i = 1 (oocyte) and 2 (zygote); 
treatj = fixed effect of treatment j, j = 1 (microdrilling) and 2 (subzonal injection); virusl 
= fixed effect of virus application l, l = 1 (sham treatment) and 2 (virus treatment); εijkl 
= random error term associated with record 1 to 22 on stage i with treatment j and 
treatment with virus l. P < 0.05 was considered significant. 
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4 Results  
4.1 Effects on embryonic development 
Early cleavage (p < 0.05) and blastocyst rates (p < 0.01) were significantly affected 
by the stage (oocyte vs. zygote) at which manipulation was performed (Table 4). 
Cleavage rates were higher when zygotes were manipulated (Table 5). Within both 
treatment groups (MI or MD), blastocyst rates were higher when virus or sham 
treatment was performed at the zygote stage (Table 5). Interestingly, the type of 
manipulation (MI vs MD) did not affect cleavage rates, but had a significant effect on 
blastocyst rates (p < 0.001; Table 4). After MI of virus or buffer, higher blastocyst 
rates were observed than after MD, both in the oocyte and zygote treatment groups 
(Table 2). To clarify if a hole in the ZP per se hampers development of bovine 
embryos, we performed mechanical slicing of the ZP at the zygote stage, opening 
about one third of the ZP and thus creating a bigger hole as compared to the MD 
technique. ZP slicing did not decrease development to blastocyst (26%; 6/23) as 
compared to non-sliced control zygotes (25%; 4/16). The viral vectors and 
interactions between the various parameters (treatment x virus; stage x virus) did not 
influence development of oocytes or zygotes (Table 4) 
 
4.2 Effects on transgene expression  
The proportion of eGFP expressing blastocysts was affected by stage (p < 0.05), 
virus (p < 0.001) and interaction of stage x virus (p < 0.05) (Table 4). A higher 
proportion of eGFP expressing blastocysts was observed when oocytes were 
infected (Table 5). 
Overall efficacy, i.e. the number of eGFP expressing blastocysts per total number of 
infected oocytes or zygotes, respectively, was influenced by treatment (p < 0.05), 
virus (p < 0.001) and the interaction of treatment x virus (p < 0.05) (Table 4). Injection 
of lentiviral particles into the perivitelline space of oocytes resulted in the highest 
proportion of eGFP expressing blastocysts (Table 5). Representative images of 
infected bovine blastocysts and negative control (bottom) are shown in Fig. 9. Bright 
field (left), fluorescence images (right).  
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Fig 9 Analysis of eGFP expression in blastocysts after lentiviral gene transfer. Representative 
images of infected bovine blastocysts and negative control (bottom). Bright field (left), 
fluorescence images (right).  
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4.3 Effect of microdrilling of oocytes on polyspermy 
Pronuclear formation in zygotes, obtained from MD oocytes, was analyzed by orcein 
staining. Fertilization rates were 83% (26/31) after incubation with 106 
spermatozoa/ml for 18 h and 87% (20/23) when 0.5 x 106 spermatozoa/ml were 
added for 8 h. The corresponding polyspermy rates were 38% (10/26) and 40% 
(8/20), respectively. After further reduction of coincubation time to 4 h, no fertilization 
was observed. A control group of zygotes (n = 20) originating from denuded fertilized 
oocytes with an intact ZP did not show signs of polyspermy. Fig. 10 shows a normally 
fertilized zygote with two pronuclei (left) and a polysperm zygote with three pronuclei 
(right). 
 
 
 
 
 
Fig 10 pronuclear formation in bovine zygotes; normally fertilized zygote (left), polysperm 
zygote (right) 
 
Results 
 41   
 
Table 4 Effects of developmental stage, treatment, virus and the interactions between these 
factors on embryonic development and transgene expression 
 
The table shows F-values and levels of significance (* p < 0.05; ** p < 0.01; *** p < 
0.001). All possible interactions between stage, treatment and virus were initially 
included in the model, but were removed from the final model if they had no 
significant effect 
 
Model 
Cleavage 
rate 
Blastocyst 
rate 
Expression 
rate 
Overall 
Efficiency 
Stage 5.95* 18.53** 5.53* 0.88 
Treatment 0.98 25.26*** 0.88 7.1* 
Virus 0.00 0.03 43,4*** 48.36*** 
Treatment x Virus 0.02 0.28 0.88 7.1* 
Stage x Virus 0.50 0.27 5.53* 0.88 
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Table 5 Embryonic development and transduction efficacies 
 
Stage Treatment Group size
n 
 
Cleavage 
rate 
[%] 
Blastocyst 
rate1 
[%] 
Expression 
rate2 
[%] 
Overall 
efficacy3 
[%] 
Oocyte MD 126 73.8 ± 5.8ab 14.4 ± 6.9c 44.0 ± 9.2fg 6.9 ± 2.3h
Oocyte Sham-MD 184 67.3 ± 4.9a 12.7 ± 6.0c   
Oocyte MI 248 74.8 ± 4.9ab 34.5 ± 6.0d 67.3 ± 8.0f 17.6 ± 2.0i
Oocyte Sham-MI 89 75.8 ± 5.8ab 39.3 ± 6.9de   
Zygote MD 218 77.7 ± 4.9ab 36.0 ± 6.0d 26.3 ± 8.0g 6.4 ± 2.0h
Zygote Sham-MD 99 85.2 ± 5.8b 31.1 ± 6.9cd   
Zygote MI 182 84.3 ± 5.8b 57.9 ± 6.9e 26.4 ±9.2g 12.3 ± 2.3hi
Zygote Sham-MI 56 82.2 ± 5.8ab 56.4 ± 6.9e   
 
The table shows the group sizes, the means and the standard error (SEM) of the 
developmental parameters. Group size results of at least three independent 
experiments. 1Blastocyst rate was calculated based on the number of cleaved 
embryos, 2expression rate is based on the total number of blastocysts. 3Overall 
efficacy is the proportion of eGFP-positive blastocysts relative to the number of 
oocytes or zygotes used. Within each column, proportions with different superscripts 
differ significantly (p < 0.05). 
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5 Discussion 
This study evaluated the efficacy of a new route of lentiviral gene transfer: MD of 
oocytes or zygotes and subsequent incubation in virus suspension. Transduction 
experiments were performed both on bovine zygotes and oocytes, because a pilot 
study demonstrated that the use of oocytes resulted in a higher yield of eGFP 
expressing blastocysts after subzonal injection of the same lentiviral vector (Hofmann 
et al., 2003).  
In our experiments the removal of cumulus cells was essential to visualize the ZP for 
micromanipulation. This causes a substantial decrease in sperm penetration rates in 
zona-intact oocytes (Tanghe et al., 2003), which may explain the lower rates of 
development after subzonal virus injection of oocytes as compared to zygotes. 
Cumulus cells are known to secrete a complex mixture of substances required for 
fertilization, since a cumulus cell-conditioned medium as well as a cumulus cell 
monolayer improved fertilization rates of denuded oocytes in comparison to cumulus 
free fertilization (Tanghe et al., 2003). 
Due to the experimental requirements of this study, the start of fertilization was 
different between the oocyte and zygote treatment groups: 24 – 25 h and 19 – 20 h 
after onset of oocyte maturation, respectively. Previous studies demonstrated that 
within a period of 21 - 24 h after the onset of maturation, the start of fertilization does 
not influence development to blastocyst (Iwata et al., 2004). Thus, it is unlikely that 
delayed fertilization was the reason for lower blastocyst rates in the oocyte treatment 
groups. 
For MD oocytes, the high degree of polyspermy is most likely responsible for the 
reduced blastocyst rate, because polyploid bovine embryos do not develop to 
blastocysts (Hyttel et al., 2001). In mice, embryonic development was not hampered 
by a hole in the ZP and polyploidy was observed only occasionally (Germond et al., 
1996). Instead, fertilization rates of microdrilled mouse oocytes and implantation 
rates of the resulting embryos were improved (Germond et al., 1996). Different hole 
diameters, which are necessary for complete hatching of blastocysts in mouse (5 to 
10 µm; Germond et al., 1996) and bovine (40 µm; Schmoll et al., 2003), could be a 
reason for the high proportion of polyspermy in our study. 
The reduced blastocyst rate after MD of bovine oocytes and zygotes as compared to 
the corresponding MI groups might be a specific consequence of laser treatment in 
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this species. A hole in the ZP did per se not hamper development of bovine embryos, 
since mechanical slicing of the ZP at the zygote stage did not decrease development 
to blastocyst as compared to non-sliced control zygotes. Laser beam is known to 
cause a disruption of the ZP due to a highly localized photo thermolysis of the protein 
matrix (Rink et al., 1996). Previous studies on MD in mouse reported no adverse 
effects on embryonic development (Germond et al., 1995). We can currently not 
explain why development of bovine oocytes and zygotes appears to be negatively 
affected by laser MD.  
The rate of eGFP expressing bovine blastocysts was higher when oocytes were 
infected with the lentiviral vector, irrespective of the route of infection (subzonal 
injection or ZP microdrilling). This finding is in line with results of a previous study, in 
which bovine oocytes and zygotes were infected with vectors derived from prototypic 
retroviruses (Moloney murine leukemia virus) by subzonal injection (Chan et al., 
1998). The authors concluded that germinal vesicle breakdown together with arrest 
of the oocyte in metaphase II prolongs exposure time of metaphase chromosomes to 
the virus. In contrast to prototypic retroviruses, lentiviruses are able to pass through 
the nuclear membrane due to a central DNA flap (Zennou et al., 2000). Nevertheless, 
virus integration might be more efficient without this barrier at the oocyte stage. 
In our study, we monitored successful lentiviral transduction of oocytes or zygotes by 
the presence of green fluorescence at the blastocyst stage. We have previously 
shown that, after lentiviral transduction of oocytes, all resulting eGFP expressing 
blastocysts, which were transferred to recipients and developed to term, gave rise to 
transgenic calves exhibiting a stable long-term eGFP expression (Hofmann et al., 
2004). Thus eGFP expression at the blastocyst stage is a clear indicator of lentiviral 
integration. In fact, this readout may even underestimate the rate of lentiviral 
transduction, because – in contrast to prior assumptions – we recently found that a 
subset of lentiviral integrants may be silenced by DNA hypermethylation (Hofmann et 
al., 2006). 
In summary, our study demonstrates the feasibility of laser-assisted lentiviral gene 
transfer into bovine oocytes and zygotes. However, further optimization of the 
procedure is required, mainly to reduce the incidence of polyspermy after ZP 
microdrilling of oocytes and to eliminate negative effects on embryonic development 
as observed in the present study.  
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Future Prospects 
Although the limitations of transgenic livestock technology, such as high costs and 
rather insufficient methods could not be overcome sufficiently, a slow but steady 
progress can be observed during the last 25 years.  
Improvement of in vitro production techniques of bovine embryos faciliates the 
application of this technique to address fundamental questions of the endocrine 
control, the molecular switches and the metabolic pathways that regulate early 
embryonic development (Galli et al., 2003). Therefore numerous reports exist, where 
this research tool is used to obtain information about transgenesis, gene targeting 
and NT in bovine in vitro (Iguma et al., 2005, Cho et al., 2004, Arat et al., 2002, Wells 
and Powell, 2000, Rosochacki et al., 2003). 
The use of transgenic cattle for agricultural purposes was much discussed, but 
practical application of transgenic technology was restricted to plants (Maga, 2005). 
Many proof-of-principle studies have been carried out, but the commercial application 
of this technology is still not existent (Clark and Whitelaw, 2003). The first report, in 
which it was demonstrated that genetic engineering of livestock might benefit animal 
agriculture, was done by Wall, et al. (2005). They produced transgenic Jersey cattle 
via NT, which expressed lysostaphin in their milk to gain resistance against 
Staphylococcus aureus infection of the mammary gland. To increase public 
acceptance for genetically modified products from animals, inducible vector systems 
were proposed, which could contribute to dispel doubts regarding the safety of 
products from the lysostaphin transgenic cows (Rainard, 2005).  
The creation of BSE resistant cattle is one more approach to introduce transgenic 
animal technology in agriculture as well as in biomedicine. The idea was to eliminate 
the risk of transmission of the disease to humans from animal products, such as milk, 
meat or proteins produced from transgenic cows. Inactivation of the PRNP-gene can 
be done via gene targeting in cultured bovine somatic cells with subsequent NT into 
enucleated oocytes. PRNP-gene deficient cattle are supposed to be resistant against 
BSE, because it could be shown that PRNP-gene deficient mice could not be 
infected with scrapie-protein. Mice carrying only one active allele of the PRNP gene 
showed a prolonged incubation time after infection, which indicated a gene-dose-
effect (Bueler et al., 1993).  
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Another promising tool for making transgenic livestock more feasible is lentiviral gene 
transfer, although until now only proof-of-principle studies with a reporter gene exist 
(Hofmann et al., 2003, Hofmann et al., 2004). Though lentiviral vectors are 
introduced into the germ-line and therefore bequeathed to the offspring, low or 
undetectable levels of expression in one-third of the proviral integrants was found. A 
inverse correlation between proviral methylation and expression level was reported, 
which indicated that DNA hypermethylation plays a major role in lentivirus silencing in 
transgenic animals (Hofmann et al., 2006).  
Another interesting and rather novel approach to exert influence on gene expression 
in animals are lentiviral vectors carrying siRNAs, which cause via RNA interference a 
knock down of genes. RNA interference (RNAi) represents an evolutionarily 
conserved cellular defense for controlling the expression of foreign genes in most 
eukaryotic cells. RNAi is triggered by double-stranded RNA (dsRNA) and causes 
sequence-specific mRNA degradation of single-stranded target RNAs homologous in 
response to dsRNA. The mediators of mRNA degradation are small interfering RNA 
duplexes (siRNAs), which are produced from long dsRNA by enzymatic cleavage in 
the cell. siRNAs are approximately twenty-one nucleotides in length, and have a 
base-paired structure characterized by two-nucleotide 3'-overhangs (Tuschl and 
Borkhardt, 2002).  
When zygotes of GFP-transgenic mice were infected with a lentiviral vector carrying 
a siRNA against GFP, the fluorescence of the resulting blastocysts was reduced. 
Furthermore pubs from F1 progeny, which expressed eGFP, showed diminished 
fluorescence and decreased GFP (Tiscornia et al., 2003, Rubinson et al., 2003). This 
technology might be an alternative approach to NT for gene knock out in farm 
animals and for studying gene function. It can be done in vitro as well as in vivo. 
Developmental capacity of embryos infected with lentiviral vectors is not hampered 
by the procedure and developmental abnormalities in resulting offspring might not 
occur (Pfeifer, 2004). Furthermore it might be used to suppress infectious pathogens, 
particularly viruses, by targeting the RNA of the invading agent (Clark and Whitelaw, 
2003) 
Until today ES cells are only available form mice. The advantages of pluripotent ES 
cells from farm animals as donor nuclei for nuclear transfer are evident, since mouse 
blastocysts from embryos reconstructed by nuclear transfer with nuclei from ES cells 
lead to a 10 – 20 fold higher efficiency than blastocysts reconstructed by SCNT with 
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cumulus cells. This indicates that ES cells are easier to reprogram (Gjorret and 
Maddox-Hyttel, 2005). Moreover, precise genetic modifications by homologous 
recombination occur at a rate of approximately two orders of magnitude higher in ES 
cells than in somatic cells (Piedrahita, 2000) and their extended in vitro live span 
allows for genetic manipulation (Gjorret and Maddox-Hyttel, 2005). Attempts to 
establish routine procedures of the monitoring of key functional ES cell parameters 
include determination of pluripotency markers, such as Oct 4 or Nanog, assessment 
of telomerase activity and cell and colony morphology (Gjorret and Maddox-Hyttel, 
2005). But so far no ES cell like cultures from other mammal animal than mouse 
could be established, which showed the characteristic parameters of immortality, 
pluripotency and propensity to targeted mutations by homologous recombination, 
combined with their capability for germ line transmission (Capecchi, 1989). 
Routine application of 1.48 µm wavelength laser technology in human assisted 
reproduction has shown to fulfill safety requirements (Germond, Nocera, et al. 1995 ) 
for performing ICSI, polar body biopsy or assisted hatching (Ebner, Moser, et al. 
2005). Comparative studies found no adverse effect of the laser drilling procedure on 
the developmental capacity of human embryos (Chatzimeletiou, Morrison, et al. ) but 
report an improvement of blastocyst formation (Tinney, Windt, et al. 2005) or 
implantation rates (Germond, Nocera, et al. 1996) in mice. However, the use of laser 
technology is rather cost-intensive and therefore only reasonable in animal embryo 
technologies when single embryos are of high value. This might be the case when a 
specific oocyte or embryo donor is used, for example in OPU programs in cattle, 
since a microdrilled opening in the ZP of IVP bovine embryos faciliates hatching of 
blastocysts (Schmoll, Schneider, et al. 2003).  
The constant search for new routes of gene transfer, the discovery of genetic 
mechanisms, which can be used for transgenic technology (RNAi) and the ongoing 
improvement of in vitro techniques provide for a slow but steady advance in the 
feasibility of large animal transgenesis. 
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6 Summary 
Lentiviral transduction of oocytes or early embryos is an efficient strategy to generate 
transgenic rodents and livestock. We evaluated laser-based microdrilling (MD) of the 
zona pellucida, which is a physical barrier for viral infection, and subsequent 
incubation in virus suspension as a new route for lentiviral transgenesis in bovine. 
Lentiviral vectors carrying an eGFP expression cassette were used to transduce 
oocytes or zygotes after MD as compared to the established subzonal virus injection 
technique (MI). The type of manipulation (MD vs. MI) did not affect cleavage rates, 
but had a significant effect on blastocyst rates (p < 0.001). MI of virus or sham-MI 
(buffer) resulted in higher blastocyst rates as compared to MD, both in the oocyte 
and zygote treatment groups. The latter exhibited higher rates of early cleavage (p < 
0.05) and blastocyst rates (p < 0.01). The proportion of eGFP expressing blastocysts 
was higher after infection of oocytes (MD: 44 ± 9%; MI: 67±8%) than after infection of 
zygotes (MD: 26 ± 8%; MI: 26 ± 9%). Overall efficacy (eGFP-positive blastocysts per 
treated oocytes or zygotes) was highest after MI of oocytes (18 ± 2%). Our study 
demonstrates the feasibility of laser-assisted lentiviral gene transfer into bovine 
oocytes and zygotes. However, further optimization of the procedure is required, 
mainly to reduce the incidence of polyspermy after MD of oocytes and to eliminate 
negative effects of MD on early embryonic development.  
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7 Zusammenfassung 
Laser-unterstützter Lentiviraler Gentransfer zur Erzeugung transgener Rinder 
Lentiviraler Gentransfer in Eizellen oder präimplantive Embryonen ist eine effiziente 
Strategie zur Erstellung transgener Nager oder Nutztiere. Die Zona pellucida stellt 
eine physikalische Barriere gegen virale Infektionen dar. Im Rahmen unserer 
Untersuchung wurde geprüft, ob das Lochen der ZP mit einem Laser, mit darauf 
folgender Inkubation der Eizellen oder Zygoten in Virus-Suspension geeignet ist, 
transgene Rinderembryonen zu erzeugen. Sowohl Oozyten wie auch Zygoten 
wurden mit dem Laser gelocht (MD) und auch subzonal mikroinjiziert (MI). Der 
verwendete Vektor enthielt eine eGFP Expressionskassette unter der Kontrolle des 
pgk Promotors. Die Art der Behandlung (MD versus MI) hatte keinen Effekt auf die 
Teilungsraten, aber einen signifikanten Einfluss auf die Blastocystenraten (p < 
0,001). Sowohl in den Eizell- als auch in den Zygotengruppen resultierte MI des Virus 
oder der Pufferlösung in höheren Blastozystenraten als in den gelochten Gruppen. In 
den Zygotengruppen konnten höhere Teilungsraten (p < 0,5) und höhere 
Blastozystenraten (p < 0,01) beobachtet werden. Der Anteil eGFP exprimierender 
Blastozysten war nach der Infektion von Eizellen (MD: 44 ± 9%; MI: 67±8%) höher 
als nach der Infektion von Zygoten (MD: 26 ± 8%; MI: 26 ± 9%). Die 
Gesamtausbeute an exprimierenden Blastozysten (eGFP positive Blastozysten pro 
behandelter Eizelle oder Zygote) war nach der MI von Eizellen am höchsten (18 ± 
2%). Unsere Untersuchung zeigt, dass Laser-unterstützter lentiviraler Gentransfer in 
bovine Eizellen und Zygoten möglich ist. Jedoch sind weitere Verbesserungen des 
Protokolls nötig, um das Auftreten von Polyspermie und die negativen Effekte der 
Laserbehandlung auf die Entwicklungskapazität von präimplantiven Embryonen zu 
reduzieren. 
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8 Publications 
This study is accepted for publication in Transgenic Research. 
 
Within this project “Lentiviral Transgenesis in farm animals” two more publications 
were produced: 
 
 
1.  Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, Stojkovic, M., 
Boelhauve M, Brem G, Wolf E, Pfeifer A, 2003: 
 Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 4 1054-
1060. 
 
2.  Hofmann A, Kessler B, Ewerling S, Kabermann A, Brem G, Wolf E, Pfeifer A, 
2006: 
 
Epigenetic regulation of lentiviral transgene vectors in a large animal model. 
Mol.Ther. 13 59-66. 
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